| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $2.26B | — | +1.9% |
| Cost of Revenue | $641.0M | — | +3.1% |
| R&D Expense | $180.0M | — | +14.6% |
| SG&A Expense | $588.0M | — | +4.4% |
| Interest Expense | $62.0M | — | +14.8% |
| Pre-tax Income | $758.0M | — | -6.4% |
| Income Tax | $157.0M | — | -12.3% |
| Net Income | $601.0M | — | -4.8% |
| EPS (Basic) | $1.42 | — | +0.7% |
| EPS (Diluted) | $1.42 | — | +0.7% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $1.94B | -20.8% | +12.8% |
| Accounts Receivable | $1.51B | -5.3% | +10.7% |
| Inventory | $2.55B | +4.9% | +7.8% |
| Current Assets | $6.47B | -4.3% | +10.2% |
| Total Assets | $15.15B | -2.0% | +7.5% |
| Current Liabilities | $2.05B | -8.1% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $401.0M | — | -31.7% |
| Capital Expenditures | $110.0M | — | -26.2% |
| Investing Cash Flow | -$87.0M | — | +50.3% |
| Financing Cash Flow | -$840.0M | — | -24.1% |
| Free Cash Flow | $291.0M | — | -33.6% |
| -39.4% |
| Long-term Debt | $9.04B | +0.0% | +73.0% |
| Total Liabilities | $11.92B | -1.8% | +26.2% |
| Stockholders' Equity | $3.23B | -2.9% | -30.5% |